funded by the Prometheus USA(www.prometheususa.org)and Vietnam National Foundation for Science&Technology Development(NAFOSTED)under grant number 108.05e2017.30.
Background:Biliary atresia is a rare congenital bile duct disease that is the leading cause of liver fibrosis in neonates.Granulocyte colony-stimulating factor(GCSF)is a potential therapy for hepatocellular diseases,b...
This study was funded by National Natural Science Foundation of China (81701847 to Y.Mao);Natural Science Foundation of Hunan Province (2017JJ3497 to Y.Mao)。
Background and aim:Percutaneous transhepatic biliary drainage(PTBD)does not always lead to a reduction in serum total bilirubin(TBil)level in patients with hepatocellular carcinoma and obstructive jaundice.We aimed to...
The 4th Chinese American Liver Society(CALS)/Society of Chinese Bioscientists in America(SCBA)Hepatology Division Annual Symposium was held virtually on October 29e30,2021.The goal of the CALS Symposium was to present...
This work was financially supported by the Vice-Chancellor of Research Affairs of Shiraz University of Medical Sciences,Shiraz,Iran(Grant No.19444).
Background and aim:Cholestasis-associated renal injury or cholemic nephropathy(CN)is a serious clinical problem.Previous studies mentioned that oxidative stress and mitochondrial impairment play a role in CN.There is ...
This study was financially supported by the Vice-Chancellor of Research Affairs of Shiraz University of Medical Sciences(Grant number:97-01-36-18730);Shanxi Agricultural University(Grant numbers:2018YJ33 and K271999031 for National Natural Science Foundation of China and Outstanding Doctors Volunteering to Work in Shanxi Province,respectively).
Background and aim:The liver is the primary organ affected by cholestasis,and complications such as renal injury,renal failure,and the need for renal transplantation are associated with cholestatic liver disease.There...
This work was supported in part by the Dr.Nicholas C.High-tower Centennial Chair of Gastroenterology from Scott&White,a Veterans Health Administration Research Career Scientist award(IK6BX004601);a VA Merit award to Dr.G.Alpini(5I01BX000574);a VA Merit Award(1I01BX001724)to Dr.F.Meng from the United States Department of Veterans Affairs Biomedical Laboratory Research;the USA National Institutes of Health(NIH)grants DK110035,DK054811,DK062975,DK115184,AA025997 and AA025157 to Drs.G.Alpini,F.Meng and S.Glaser.
Cholangiopathies are caused by bile duct damage or inflammation followed by cholestasis leading to liver fibrosis.Bile duct epithelial cells,cholangiocytes,are a primary target for cholangiopathies.Ductular reaction i...
This work was supported by US NIH grant R21DK100897(to Dr.C.L.Bowlus).
Primary sclerosing cholangitis(PSC)is a rare,chronic,cholestatic liver disease of uncertain etiology characterized biochemically by cholestasis and histologically and cholangiographically by fibroobliterative inflamma...
This work was supported in part by the National Institutes of Health grants DK083952 and HD073070(to W.X.).
Background and Aim:Sulfotransferase(SULT)-mediated sulfation and steroid sulfatase(STS)-mediated desulfation represent two critical mechanisms that regulate the chemical and functional homeostasis of endogenous and ex...